Cyclerion Therapeutics, Inc. (CYCN) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cyclerion Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.16x | -2.65x | -1.49x | -0.65x | -1.30x | -1.20x |
| P/B Ratio | 0.45x | 0.92x | 0.69x | 2.73x | 1.40x | 1.56x |
| P/S Ratio | 1.97x | 4.05x | 0.00x | 95.99x | 20.28x | 40.52x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 0.0% | -1778.5% | 100.0% | -2357.1% |
| Operating Margin | -239.8% | -181.4% | 0.0% | -6242.4% | -1662.5% | -3539.4% |
| Net Margin | -170.1% | -152.8% | 0.0% | -14841.1% | -1555.6% | -3388.6% |
| EBITDA Margin | -239.8% | -181.4% | 0.0% | -6220.5% | -1621.7% | -3512.1% |
| Liquidity | ||||||
| Current Ratio | 5.15x | 5.83x | 3.85x | 1.94x | 5.00x | 3.45x |
| Quick Ratio | 5.15x | 5.83x | 3.85x | 1.94x | 4.92x | 3.45x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.77x |
YoY = year-over-year change. Source: FMP..